Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN
The study aimed to create D-α-Tocopherol polyethylene glycol 1000 succinate (TPGS) nanostructured lipid carriers (NLC) of sorafenib tosylate (ST) as lymphatic delivery systems (LDDS) to fight Metastatic colorectal cancer. Initially, ST-SLN, ST-NLC, and ST-LNE were formulated considering oleic acid (...
Main Authors: | Sankha Bhattacharya, Satyam Sharma, Bhupendra G. Prajapati |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.990841/full |
Similar Items
-
Development of α-Tocopherol Succinate-Based Nanostructured Lipid Carriers for Delivery of Paclitaxel
by: Sushrut Marathe, et al.
Published: (2022-05-01) -
Structural Polymorphism of Sorafenib Tosylate as a Key Factor in Its Solubility Differentiation
by: Gabriela Wiergowska, et al.
Published: (2021-03-01) -
Impact of Crystal Habit on the Dissolution Rate and In Vivo Pharmacokinetics of Sorafenib Tosylate
by: Chi Uyen Phan, et al.
Published: (2021-06-01) -
Crystal Structure, Stability and Desolvation of the Solvates of Sorafenib Tosylate
by: Peng Yang, et al.
Published: (2019-07-01) -
Multiple Functions of D-α-Tocopherol Polyethylene Glycol 1000 Succinate (TPGS) as Curcumin Nanoparticle Stabilizer: In Vivo Kinetic Profile and Anti-Ulcerative Colitis Analysis in Animal Model
by: Heni Rachmawati, et al.
Published: (2017-07-01)